I-Mab (NASDAQ:IMAB – Get Rating) and Iterum Therapeutics (NASDAQ:ITRM – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations. Risk & Volatility I-Mab has a beta of 0.94, indicating […]
/PRNewswire/ Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),.
Ascentage Pharma Announces 2021 Annual Results with Commercialization Programs Going Full Steam Ahead streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Sinopharm Group Co., Ltd. (OTCMKTS:SHTDF – Get Rating)’s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.40 and traded as low as $2.21. Sinopharm Group shares last traded at $2.25, with a volume of 9,377 shares changing hands. […]
Ukraine’s conflict has knock-on effects on the Covid-19 pandemic as supplies of Sputnik V vaccine to Asian, African, and South American countries now in question.